Tiziana Life Sciences CEO to Speak at ROTH Conference
Ticker: TLSA · Form: 6-K · Filed: Mar 17, 2025 · CIK: 1723069
Sentiment: neutral
Topics: conference, investor-relations
TL;DR
Tiziana CEO Ivor Elrifi speaking at ROTH Conference March 16-18, 2025. Investor meetings planned.
AI Summary
Tiziana Life Sciences LTD announced on March 17, 2025, that its CEO, Ivor Elrifi, will participate in a fireside chat and host investor meetings at the 37th Annual ROTH Conference. The conference takes place from March 16-18, 2025.
Why It Matters
This presentation offers an opportunity for investors to gain insights into the company's strategy and potential from its leadership.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a CEO's participation in a conference and does not contain significant financial or operational news.
Key Players & Entities
- Tiziana Life Sciences LTD (company) — Registrant
- Ivor Elrifi (person) — CEO of Tiziana Life Sciences
- 37th Annual ROTH Conference (company) — Event
- March 17, 2025 (date) — Announcement Date
- March 16-18, 2025 (date) — Conference Dates
FAQ
What is the purpose of Tiziana Life Sciences' participation in the 37th Annual ROTH Conference?
The company's CEO, Ivor Elrifi, will be presenting during a fireside chat and hosting 1x1 investor meetings.
When is the 37th Annual ROTH Conference being held?
The conference is being held from March 16-18, 2025.
Who is representing Tiziana Life Sciences at the ROTH Conference?
The CEO of Tiziana Life Sciences, Ivor Elrifi, will be presenting and hosting meetings.
On what date did Tiziana Life Sciences issue this announcement?
The announcement was issued on March 17, 2025.
What is the principal executive office address of Tiziana Life Sciences LTD?
The principal executive office is located at 9th Floor, 107 Cheapside, London EC2V 6DN.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 17, 2025 by Ivor Elrifi regarding Tiziana Life Sciences Ltd (TLSA).